is retatrutide a glp-1 drug triple agonist gip glucagon phase 2 trial obesity First-in-Class 'Triple-G'! Weight loss drug retatrutide use

Side effect logging, tracking nausea severity, GI symptoms, and any other effects after each injection, helps quantify whether microdosing is actually reducing your side effect burden

Stimulation of GLP-1R Attenuates MG-Induced Mitochondrial Dysfunction in a cAMP-Dependent Pathway According to stimulation of GLP-1R promotes the activation of AC activity through G s protein, and subsequent elevation of cAMP levels, we determined whether the inhibition of MG-induced mitochondrial dysfunction by exendin-4 is dependent of cAMP

If a patient successfully lost the desired amount of weight and feels confident they can stick to the diet and exercise plan, they may begin to taper off the medication

Lancet 357, 354357

As a result, retatrutide has emerged as a valuable research tool for studying obesity, type 2 diabetes mellitus, insulin resistance, metabolic dysfunction-associated steatotic liver disease (MASLD/NASH), cardiovascular-metabolic disorders, and energy homeostasis